Apollon Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
ETC
Apollon Wealth Management's MDT Position: Q2 2026 in Review
Apollon Wealth Management increased its Medtronic (MDT) stake by 41% in Q2 2026, buying an estimated $1.65M and bringing the position to 70,557 shares worth $5.52M. The position accounts for 0.07% of the portfolio, ranked #251.
Apollon Wealth Management first reported a position in MDT in Q2 2020 and has held it in 23 quarters since. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Apollon Wealth Management held 70,557 shares of Medtronic worth $5.52M as of Q2 2026.
- Apollon Wealth Management bought 20,438 Medtronic shares in Q2 2026, an estimated $1.65M.
- Medtronic made up 0.07% of Apollon Wealth Management's portfolio in Q2 2026, its #251 holding.
- Apollon Wealth Management first reported a position in Medtronic in Q2 2020 and has held it in 23 quarters since.
- 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.